Baker Tilly Wealth Management, LLC Abbott Laboratories Transaction History

Baker Tilly Wealth Management, LLC

$377 Million
Q4 2025

A detailed history of Baker Tilly Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 2,436 shares of ABT stock, worth $316,753. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,436

Previous 3,442 29.23%

Holding current value

$316,753

Previous $461,000 31.45%

% of portfolio

0.08%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 08, 2026	SELL	$123.62 - $134.59 $124,361 - $135,397	-1,006 Reduced 29.23%	2,436 $316,000
Q3 2025 Oct 09, 2025	SELL	$120.51 - $136.62 $246,924 - $279,934	-2,049 Reduced 37.32%	3,442 $461,000
Q2 2025 Jul 10, 2025	BUY	$123.95 - $138.08 $223,481 - $248,958	1,803 Added 48.89%	5,491 $746,000
Q1 2025 Apr 09, 2025	SELL	$111.1 - $140.22 $36,885 - $46,553	-332 Reduced 8.26%	3,688 $489,000
Q4 2024 Jan 10, 2025	BUY	$111.93 - $119.39 $3,581 - $3,820	32 Added 0.8%	4,020 $454,000

Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $212,948 - $251,380	-2,128 Reduced 34.79%	3,988 $454,000
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $2.23 Million - $2.48 Million	-22,097 Reduced 78.32%	6,116 $635,000
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $546,504 - $603,590	4,990 Added 21.49%	28,213 $3.21 Million
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $250,998 - $307,243	-2,783 Reduced 10.7%	23,223 $2.56 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $711,698 - $853,919	-7,450 Reduced 22.27%	26,006 $2.52 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $705 - $786	7 Added 0.02%	33,456 $3.65 Million
Q1 2023 Apr 12, 2023	SELL	$96.86 - $114.01 $264,524 - $311,361	-2,731 Reduced 7.55%	33,449 $3.39 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $23,194 - $27,210	-244 Reduced 0.67%	36,180 $0
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $123,756 - $143,286	-1,279 Reduced 3.39%	36,424 $3.52 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $1.71 Million - $2.06 Million	-16,707 Reduced 30.71%	37,703 $4.1 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $605,218 - $738,024	5,308 Added 10.81%	54,410 $6.44 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $782,831 - $958,532	6,776 Added 16.01%	49,102 $6.91 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $588,199 - $650,720	5,042 Added 13.52%	42,326 $5 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $314,196 - $369,854	2,970 Added 8.66%	37,284 $4.32 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $574,239 - $676,541	5,276 Added 18.17%	34,314 $4.11 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $3.05 Million - $3.32 Million	29,038 New	29,038 $3.18 Million

Others Institutions Holding ABT

# of Institutions

3,641

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Account

Baker Tilly Wealth Management, LLC Abbott Laboratories Transaction History